BLOOD TESTS | Reference Range | OTHER TESTS | Reference Range | ||
---|---|---|---|---|---|
White blood cells (WBC)/μL | 6420 | 5000–15,000 | Mantoux TST (mm) | 12a | < 10.0 |
Neutrophils/μL | 4980 | 1300–8500 | Fecal calprotectin (μg/g) | < 15.0 | < 90.0 |
Lymphocytes/μL | 770 | 1300–8500 | Urinalysis | Negative | Negative |
Hemoglobin (g/dL) | 11.7 | 10.5–14.0 | Blood culture | Negative | Negative |
Platelets/μL | 601,000 | 140,000–440,000 | Blood smear | Anisocytosis, microcytosis, poikilocytosis, band cells (rare), manteined formula | |
C-reactive protein (mg/L) | 132.3 | 0.0–5.0 | Ascitic fluid analysis | Leukocites 3979/μL Proteins > 1000 mg/dL SAAG < 1.1 g/dL | |
Glucose (mmol/L) | 4.5 | 3.3–6.1 | Ascitic fluid citology | Lymphocyte predominance No atipical or bizzare cells | |
Iron (μg/dL) | 15.0 | 30–120 | ECG | Negative | Negative |
Albumin (g/dL) | 3.4 | 3.4–4.8 | Cardiac US | Negative | Negative |
Total protein (g/dL) | 7.0 | 6.0–8.0 | Interferon Gamma Release Assay - IGRA (first evaluation) | 0.39 | <0.35 |
Sodium (mEq/L) | 138.0 | 135–145 | Interferon Gamma Release Assay - IGRA (second evaluation) | 1.62 | <0.35 |
Potassium (mEq/L) | 3.5 | 3.4–5.5 | Ziehl-Nielsen (ZN) staining (3 gastric aspirates) | Negative | Negative |
Chloride (mEq/L) | 97.0 | 96.0–115.0 | Culture for acid-alcohol resistant bacilli (3 gastric aspirates) | Negative | Negative |
Calcium (mg/dL) | 8.8 | 8.6–11.0 | Polymerase Chain Reaction (PCR) - Gene Xpert (3 gastric aspirates) | Negative | Negative |
Creatinine (mg/dL) | 0.58 | 0.30–0.80 | Vidal agglutination test | Negative | Negative |
Urea (mg/dL) | 10.0 | 10.0–38.0 | Wright agglutination test | Negative | Negative |
eGFR (ml/min/1.73 m2) | 121.38 | 93–129.6 | CMV-IgG (U/mL) | < 5.0 | < 12.0 |
AST (U/L) | 24.0 | 5.0–58.0 | CMV-IgM (U/mL) | 8.07 | < 18.0 |
ALT (U/L) | 10.0 | 8.0–40.0 | HSV I/II-IgG | Positive | Negative |
GGT (U/L) | 13.0 | 12.0–64.0 | HSV I/II-IgM | Negative | Negative |
PT- INR | 1.1 | 0.8–1.2 | Rubella-IgG (IU/mL) | 85.7 | < 9.0 |
Fibrinogen (mg/dL) | 413.0 | 180.0–400.0 | Rubella-IgM (IU/mL) | Negative | Negative |
Amylase (U/L) | 32.0 | 10.0–80.0 | EBV-VCA-IgG (UA/mL) | 137 | < 20.0 |
IgG (mg/dL) | 1030.0 | 650.0–1600.0 | EBV-VCA-IgM (UA/mL) | < 10.0 | < 20.0 |
IgA (mg/dL) | 286 | 40.0–350.0 | |||
IgM (mg/dL) | 104.0 | 50.0–300.0 | |||
tTg IgA (CU) | 8.4 | < 15.0 | |||
BetaHCG (mIU/mL) | < 1.0 | < 5.0 | |||
AFP (ng/mL) | 0.9 | < 15.0 | |||
CEA (ng/mL) | 0.6 | 0.0–4.0 | |||
Ca19–9 (U/mL) | 14.7 | 0.0–37.0 | |||
Ca125 (U/mL) | 472 | 0.0–35.0 | |||
FSH (mU/mL) | 0.2 | < 5.0 | |||
LH (mU/mL) | < 0.1 | < 5.1 | |||
Prolactin (ng/mL) | 16.3 | 3.0–24.0 | |||
Estradiol (pg/mL) | 21.0 | 5.0–20.0 | |||
Testosterone (ng/dL) | < 20.0 | < 20.0 |